HS-173, a Novel PI3K Inhibitor, Attenuates the Activation of Hepatic Stellate Cells in Liver Fibrosis
Mi Kwon Son(Korea National University of Transportation), Soon‐Sun Hong(Inha University)
Cited by 78
Related Papers
A novel imidazopyridine PI3K inhibitor with anticancer activity in non-small cell lung cancer cells
|Oncology Reports|2013|51
SB365, Pulsatilla saponin D suppresses proliferation and induces apoptosis of pancreatic cancer cells
|Oncology Reports|2013|40
Synergistic Renoprotective Effect of Melatonin and Zileuton by Inhibition of Ferroptosis <i>via</i> the AKT/mTOR/NRF2 Signaling in Kidney Injury and Fibrosis
|Biomolecules & Therapeutics|2023|35
Apoptotic Effects of <i>Xanthium strumarium</i> via PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma
|Evidence-based Complementary and Alternative Medicine|2019|18
HS-104, a PI3K inhibitor, enhances the anticancer efficacy of gemcitabine in pancreatic cancer
|International Journal of Oncology|2014|14